Yesterday, the EVP, CBO, GC & Secretary of Karyopharm Therapeutics (KPTI – Research Report), Christopher Brett Primiano, sold shares of
Category: Healthcare
A Director at Zoetis is Exercising Options
Yesterday it was reported that a Director at Zoetis (ZTS – Research Report), Juan Ramon Alaix, exercised options to sell
The EVP HR of Incyte (NASDAQ: INCY) is Selling Shares
Yesterday, the EVP HR of Incyte (INCY – Research Report), Paula Swain, sold shares of INCY for $200K. In addition
Cowen & Co. Remains a Buy on Esperion (ESPR)
Cowen & Co. analyst Chris Shibutani maintained a Buy rating on Esperion (ESPR – Research Report) yesterday and set a
William Blair Maintains Their Buy Rating on BioMarin Pharmaceutical (BMRN)
In a report released today, Tim Lugo from William Blair maintained a Buy rating on BioMarin Pharmaceutical (BMRN – Research
Analysts Have Conflicting Sentiments on These Healthcare Companies: VistaGen Therapeutics (NASDAQ: VTGN), Beyondspring (NASDAQ: BYSI) and Agenus (NASDAQ: AGEN)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on VistaGen Therapeutics (VTGN – Research
The SVP, Global Mfg and Quality of Luminex (NASDAQ: LMNX) is Selling Shares
Today, the SVP, Global Mfg and Quality of Luminex (LMNX – Research Report), Randall Myers, sold shares of LMNX for